Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial.

Autor: Heinzerling JH; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA. Electronic address: john.heinzerling@atriumhealth.org., Mileham KF; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Robinson MM; Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Symanowski JT; Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Induru RR; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Brouse GM; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Corso CD; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Prabhu RS; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Haggstrom DE; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Moeller BJ; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Bobo WE; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Fasola CE; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Thakkar VV; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Pal SE; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Gregory JM; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Norek SL; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Begic XJ; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Kesarwala AH; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA., Burri SH; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Simone CB 2nd; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; New York Proton Center, New York, NY, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.

Dosimetric Analysis of Intra-Fraction Motion Detected by Surface-Guided Radiation Therapy During Linac Stereotactic Radiosurgery.

Autor: Foster RD; Levine Cancer Institute, Atrium Health, Concord, North Carolina., Moeller BJ; Levine Cancer Institute, Atrium Health and Southeast Radiation Oncology Group, Charlotte, North Carolina., Robinson M; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Bright M; Levine Cancer Institute, Atrium Health, Concord, North Carolina., Ruiz JL; Levine Cancer Institute, Atrium Health, Concord, North Carolina., Hampton CJ; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Heinzerling JH; Levine Cancer Institute, Atrium Health and Southeast Radiation Oncology Group, Charlotte, North Carolina.

Publikováno v: Advances in radiation oncology [Adv Radiat Oncol] 2022 Dec 27; Vol. 8 (3), pp. 101151. Date of Electronic Publication: 2022 Dec 27 (Print Publication: 2023).

The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review.

Autor: Heinzerling JH; Levine Cancer Institute, Atrium Health, Southeast Radiation Oncology, Charlotte, NC, USA., Mileham KF; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Simone CB 2nd; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; New York Proton Center, New York, NY, USA.

Publikováno v: Translational cancer research [Transl Cancer Res] 2021 May; Vol. 10 (5), pp. 2596-2608.

The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymoma.

Autor: Prabhu RS; Levine Cancer Institute, Atrium Health, Charlotte, NC.; Southeast Radiation Oncology Group, Charlotte, NC., Corso CD; Levine Cancer Institute, Atrium Health, Charlotte, NC.; Southeast Radiation Oncology Group, Charlotte, NC., Ward MC; Levine Cancer Institute, Atrium Health, Charlotte, NC., Heinzerling JH; Levine Cancer Institute, Atrium Health, Charlotte, NC., Dhakal R; Levine Cancer Institute, Atrium Health, Charlotte, NC., Buchwald ZS; Winship Cancer Institute and Emory University, Atlanta, GA., Patel KR; Kaiser Permanente, Atlanta, GA., Asher AL; Carolina Neurosurgery and Spine Associates, Charlotte, NC., Sumrall AL; Levine Cancer Institute, Atrium Health, Charlotte, NC., Burri SH; Levine Cancer Institute, Atrium Health, Charlotte, NC.

Publikováno v: Neuro-oncology practice [Neurooncol Pract] 2020 Jul; Vol. 7 (4), pp. 391-399. Date of Electronic Publication: 2019 Dec 19.

Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.

Autor: Prabhu RS; 1Levine Cancer Institute, Atrium Health.; 2Southeast Radiation Oncology Group; and., Miller KR; 1Levine Cancer Institute, Atrium Health., Asher AL; 1Levine Cancer Institute, Atrium Health.; 3Carolina Neurosurgical and Spine Associates, Charlotte, North Carolina., Heinzerling JH; 1Levine Cancer Institute, Atrium Health.; 2Southeast Radiation Oncology Group; and., Moeller BJ; 1Levine Cancer Institute, Atrium Health.; 2Southeast Radiation Oncology Group; and., Lankford SP; 1Levine Cancer Institute, Atrium Health.; 2Southeast Radiation Oncology Group; and., McCammon RJ; 1Levine Cancer Institute, Atrium Health.; 2Southeast Radiation Oncology Group; and., Fasola CE; 1Levine Cancer Institute, Atrium Health.; 2Southeast Radiation Oncology Group; and., Patel KR; 4Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut; and., Press RH; 5Department of Radiation Oncology, Emory University and Winship Cancer Institute, Atlanta, Georgia., Sumrall AL; 1Levine Cancer Institute, Atrium Health., Ward MC; 1Levine Cancer Institute, Atrium Health.; 2Southeast Radiation Oncology Group; and., Burri SH; 1Levine Cancer Institute, Atrium Health.; 2Southeast Radiation Oncology Group; and.

Publikováno v: Journal of neurosurgery [J Neurosurg] 2018 Dec 14; Vol. 131 (5), pp. 1387-1394. Date of Electronic Publication: 2018 Dec 14 (Print Publication: 2019).